Stay updated on Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial
Sign up to get notified when there's something new on the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page.

Latest updates to the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page
- Check5 days agoChange DetectedThe page shows a minor site revision update: an addition of Revision: v3.3.4 and a removal of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded Locations section with Gyeonggi-do; removed the separate 'Gyeonggi-do Locations' heading and updated to v3.3.3.SummaryDifference0.2%

- Check55 days agoChange DetectedTwo editorial updates were made: the Publications note wording changed slightly, and the page revision tag was updated from v3.2.0 to v3.3.2. These are minor updates and do not affect study data or results.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded Tainan, Taiwan to the Locations section and replaced Tainan City, Taiwan. Removed the funding-status notice about government funding at the top of the page.SummaryDifference0.3%

- Check76 days agoChange DetectedThe study details appear unchanged between the two screenshots. No substantive edits to core information such as study status, design, eligibility criteria, or endpoints are visible.SummaryDifference0.3%

- Check105 days agoChange DetectedUpdated operating status notice and version to v3.2.0, replacing v3.1.0.SummaryDifference4%

Stay in the know with updates to Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page.